|
1
|
Yuan BZ, Miller MJ, Keck CL, Zimonjic DB,
Thorgeirsson SS and Popescu NC: Cloning, characterization, and
chromosomal localization of a gene frequently deleted in human
liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res.
58:2196–2199. 1998.
|
|
2
|
Yuan BZ, Zhou X, Durkin ME, et al: DLC-1
gene inhibits human breast cancer cell growth and in vivo
tumorigenicity. Oncogene. 22:445–450. 2003.
|
|
3
|
Lahoz A and Hall A: DLC1: a significant
GAP in the cancer genome. Genes Dev. 22:1724–1730. 2008.
|
|
4
|
Yuan BZ, Jefferson AM, Baldwin KT,
Thorgeirsson SS, Popescu NC and Reynolds SH: DLC-1 operates as a
tumor suppressor gene in human non-small cell lung carcinomas.
Oncogene. 23:1405–1411. 2004.
|
|
5
|
Wong CM, Yam JW, Ching YP, et al: Rho
GTPase-activating protein deleted in liver cancer suppresses cell
proliferation and invasion in hepatocellular carcinoma. Cancer Res.
65:8861–8868. 2005.
|
|
6
|
Healy KD, Hodgson L, Kim TY, et al: DLC-1
suppresses non-small cell lung cancer growth and invasion by
RhoGAP-dependent and independent mechanisms. Mol Carcinog.
47:326–337. 2008.
|
|
7
|
Farazi PA and DePinho RA: Hepatocellular
carcinoma pathogenesis: from genes to environment. Nat Rev Cancer.
6:674–687. 2006.
|
|
8
|
Amin R and Mishra L: Liver stem cells and
tgf-Beta in hepatic carcinogenesis. Gastrointest Cancer Res. 2(4
Suppl): S27–S30. 2008.
|
|
9
|
Llovet JM, Ricci S, Mazzaferro V, et al;
SHARP Investigators Study Group. Sorafenib in advanced
hepatocellular carcinoma. N Engl J Med. 359:378–390. 2008.
|
|
10
|
Bosman FT, Carneiro F, Hruban RH and
Theise ND: WHO Classification of Tumours of the Digestive System.
3. 4th edition. IARC; Lyon: 2010
|
|
11
|
Stahl J and Voyvodic F: Biopsy diagnosis
of malignant versus benign liver ‘nodules’: new helpful markers. An
update Adv Anat Pathol. 7:230–239. 2000.
|
|
12
|
Cremer M, Grasser F, Lanctôt C, et al:
Multicolor 3D fluorescence in situ hybridization for imaging
interphase chromosomes. Methods Mol Biol. 463:205–239. 2008.
|
|
13
|
Durkin ME, Avner MR, Huh CG, Yuan BZ,
Thorgeirsson SS and Popescu NC: DLC-1, a Rho GTPase-activating
protein with tumor suppressor function, is essential for embryonic
development. FEBS Lett. 579:1191–1196. 2005.
|
|
14
|
Yang X, Popescu NC and Zimonjic DB: DLC1
interaction with S100A10 mediates inhibition of in vitro cell
invasion and tumorigenicity of lung cancer cells through a
RhoGAP-independent mechanism. Cancer Res. 71:2916–2925. 2011.
|
|
15
|
Feng M, Huang B, Du Z, Xu X and Chen Z:
DLC-1 as a modulator of proliferation, apoptosis and migration in
Burkitt’s lymphoma cells. Mol Biol Rep. 38:1915–1920. 2011.
|
|
16
|
Zhang T, Zheng J, Liu C and Lu Y:
Expression of DLC-1 in clear cell renal cell carcinoma: prognostic
significance for progression and metastasis. Urol Int. 82:380–387.
2009.
|
|
17
|
Heering J, Erlmann P and Olayioye MA:
Simultaneous loss of the DLC1 and PTEN tumor suppressors enhances
breast cancer cell migration. Exp Cell Res. 315:2505–2514.
2009.
|
|
18
|
Hankins GR, Sasaki T, Lieu AS, et al:
Identification of the deleted in liver cancer 1 gene, DLC1, as a
candidate meningioma tumor suppressor. Neurosurgery. 63:771–781.
2008.
|
|
19
|
Wong CM, Lee JM, Ching YP, Jin DY and Ng
IO: Genetic and epigenetic alterations of DLC-1 gene in
hepatocellular carcinoma. Cancer Res. 63:7646–7651. 2003.
|
|
20
|
Wu SD, Ma YS, Fang Y, Liu LL, Fu D and
Shen XZ: Role of the microenvironment in hepatocellular carcinoma
development and progression. Cancer Treat Rev. 38:218–225.
2011.
|
|
21
|
Lewis CE and Pollard JW: Distinct role of
macrophages in different tumor microenvironments. Cancer Res.
66:605–612. 2006.
|
|
22
|
Amann T, Bataille F, Spruss T, et al:
Activated hepatic stellate cells promote tumorigenicity of
hepatocellular carcinoma. Cancer Sci. 100:646–653. 2009.
|
|
23
|
Ramaiah SK and Rittling S:
Pathophysiological role of osteopontin in hepatic inflammation,
toxicity, and cancer. Toxicol Sci. 103:4–13. 2008.
|
|
24
|
Rittling SR and Chambers AF: Role of
osteopontin in tumour progression. Br J Cancer. 90:1877–1881.
2004.
|
|
25
|
Takafuji V, Forgues M, Unsworth E,
Goldsmith P and Wang XW: An osteopontin fragment is essential for
tumor cell invasion in hepatocellular carcinoma. Oncogene.
26:6361–6371. 2007.
|
|
26
|
Zhou X, Zimonjic DB, Park SW, Yang XY,
Durkin ME and Popescu NC: DLC1 suppresses distant dissemination of
human hepatocellular carcinoma cells in nude mice through reduction
of RhoA GTPase activity, actin cytoskeletal disruption and
down-regulation of genes involved in metastasis. Int J Oncol.
32:1285–1291. 2008.
|
